The Effects of Galantamine on the Kinetics of Heteromeric Nicotinic Acetylcholine Receptors

Authors

Sean Georgi, Brigham Young University
Dr. Sterling Sudweeks, Brigham Young University

Keywords

galantamine, kinetics, nicotinic acetylocholine receptors, nAChR

College

Life Sciences

Department

Physiology and Developmental Biology

Abstract

Modern medicine has dramatically increased the lifespan of individuals in industrialized societies, leading to large populations of elderly adults. With this lengthened lifespan, however, has come an increased incidence in age-related diseases such as Alzheimer’s disease. The causes of these diseases are enigmatic and complex, making them difficult to cure or prevent. Rather, current treatments try to delay or slow the progression of such diseases. One such treatment for Alzheimer’s disease involves the drug galantamine, derived from a natural compound in daffodil bulbs. Studies have begun to elucidate the mechanisms through which galantamine alleviates Alzheimer’s disease symptoms, and this project’s aim is to further that understanding.

Recommended Citation

Georgi, Sean and Sudweeks, Dr. Sterling (2013) "The Effects of Galantamine on the Kinetics of Heteromeric Nicotinic Acetylcholine Receptors," Journal of Undergraduate Research: Vol. 2013: Iss. 1, Article 1414.
Available at: https://scholarsarchive.byu.edu/jur/vol2013/iss1/1414